Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 34
1.
J Infect Chemother ; 2024 Mar 01.
Article En | MEDLINE | ID: mdl-38432557

BACKGROUND: MRSA (methicillin-resistant Staphylococcus aureus)-infective endocarditis (IE) is associated with high morbidity and mortality. This study aimed to assess data from patients with MRSA-IE across multiple facilities in Japan, with a specific focus on antimicrobial therapy and prognosis. METHODS: This retrospective study enrolled patients with a confirmed diagnosis of IE attributed to MRSA, spanning the period from January 2015 to April 2019. RESULTS: Sixty-four patients from 19 centers were included, with a median age of 67 years. The overall mortality rate was 28.1% at 30 days, with an in-hospital mortality of 45.3%. The most frequently chosen initial anti-MRSA agents were glycopeptide in 67.2% of cases. Daptomycin and linezolid were selected as initial therapy in 23.4% and 17.2% of cases, respectively. Approximately 40% of all patients underwent medication changes due to difficulty in controlling infection or drug-related side effects. Significant prognostic factors by multivariable analysis were DIC for 30-day mortality and surgical treatment for 30-day and in-hospital mortality. For vancomycin as initial monotherapy, there was a trend toward a worse prognosis for 30-day and in-hospital mortality (OR, 6.29; 95%CI, 1.00-39.65; p = 0.050, OR, 3.61; 95%CI, 0.93-14.00; p = 0.064). Regarding the choice of initial antibiotic therapy, statistical analysis did not show significant differences in prognosis. CONCLUSION: Glycopeptide and daptomycin were the preferred antibiotics for the initial therapy of MRSA-IE. Antimicrobial regimens were changed for various reasons. Prognosis was not significantly affected by choice of antibiotic therapy (glycopeptide, daptomycin, linezolid), but further studies are needed to determine which antimicrobials are optimal as first-line agents.

2.
Nat Commun ; 14(1): 5101, 2023 Sep 20.
Article En | MEDLINE | ID: mdl-37730797

In shallow subduction zones, fluid behavior impacts various geodynamic processes capable of regulating slip behaviors and forming mud volcanoes. However, evidence of structures that control the fluid transfer within an overriding plate is limited and the physical properties at the source faults of slow earthquakes are poorly understood. Here we present high-resolution seismic velocity models and reflection images of the Hyuga-nada area, Japan, where the Kyushu-Palau ridge subducts. We image distinct kilometer-wide columns in the upper plate with reduced velocities that extend vertically from the seafloor down to 10-13 km depth. We interpret the low-velocity columns as damaged zones caused by seamount subduction and suggest that they serve as conduits, facilitating vertical fluid migration from the plate boundary. The lateral variation in upper-plate velocity and seismic reflectivity along the plate boundary correlates with the distribution of slow earthquakes, indicating that the upper-plate drainage system controls the complex pattern of seismic slip at subduction faults.

3.
J Med Case Rep ; 17(1): 9, 2023 Jan 10.
Article En | MEDLINE | ID: mdl-36624479

BACKGROUND: Gram staining is a classic but standard and essential procedure for the prompt selection of appropriate antibiotics in an emergency setting. Even in the era of sophisticated medicine with technically developed machinery, it is not uncommon that a classic procedure such as Gram staining is the most efficient for assisting physicians in making therapeutic decisions in a timely fashion. CASE PRESENTATION: A 65-year-old Asian man with alcoholic cirrhosis complicated by esophageal varices was brought to the emergency division of Saga Medical School Hospital in early August, complaining of severe pain, redness, swelling, and purpura of the lower extremities. On physical examination he appeared in a critically ill condition suggestive of deep-seated soft tissue infection, raising a pre-test probability of streptococci, staphylococci, Vibrio sp., or Aeromonas sp. as a causative pathogen. A characteristic of his residency in an estuarine area is that raw seafood ingestion, as documented in this patient prior to the current admission, predisposes those who have a chronic liver disease to a life-threatening Vibrio vulnificus infection. Given the pathognomonic clinical features suggestive of necrotizing fasciitis, our immediate attempt was to narrow down the differential list of candidate pathogens by obtaining clinical specimens for microbiological investigation, thus inquiring about the post-test probability of the causative pathogen. The Gram stain of the small amount of discharge from the test incision of the affected lesion detected Gram-negative rods morphologically compatible with V. vulnificus. After two sets of blood culture, intravenous meropenem and minocycline were immediately administered before the patient underwent emergency surgical debridement. The next day, both blood culture and wound culture retrieved Gram-negative rods, which were subsequently identified as V. vulnificus by mass spectrometry, matrix-assisted laser desorption/ionization. The antibiotics were switched to intravenous ceftriaxone and minocycline. CONCLUSION: The pre-test probability of V. vulnificus infection was further validated by on-site Gram staining in the emergency division. This case report highlights the significance of a classic procedure.


Fasciitis, Necrotizing , Vibrio Infections , Vibrio vulnificus , Male , Humans , Aged , Fasciitis, Necrotizing/therapy , Minocycline , Anti-Bacterial Agents/therapeutic use , Vibrio Infections/complications , Vibrio Infections/diagnosis , Vibrio Infections/drug therapy , Staining and Labeling
4.
J Glob Antimicrob Resist ; 29: 247-252, 2022 06.
Article En | MEDLINE | ID: mdl-35429667

OBJECTIVES: The dissemination of difficult-to-treat carbapenem-resistant Enterobacterales (CRE) is of great concern. We clarified the risk factors underlying CRE infection mortality in Japan. METHODS: We conducted a retrospective, multicentre, observational cohort study of patients with CRE infections at 28 university hospitals from September 2014 to December 2016, using the Japanese National Surveillance criteria. Clinical information, including patient background, type of infection, antibiotic treatment, and treatment outcome, was collected. The carbapenemase genotype was determined using PCR sequencing. Multivariate analysis was performed to identify the risk factors for 28-day mortality. RESULTS: Among the 179 patients enrolled, 65 patients (36.3%) had bloodstream infections, with 37 (20.7%) infections occurring due to carbapenemase-producing Enterobacterales (CPE); all carbapenemases were of IMP-type (IMP-1: 32, IMP-6: 5). Two-thirds of CPE were identified as Enterobacter cloacae complex. Combination therapy was administered only in 46 patients (25.7%), and the 28-day mortality rate was 14.3%. Univariate analysis showed that solid metastatic cancer, Charlson Comorbidity Index ≥3, bloodstream infection, pneumonia, or empyema, central venous catheters, mechanical ventilation, and prior use of quinolones were significant risk factors for mortality. Multivariate analysis revealed that mechanical ventilation (OR: 6.71 [1.42-31.6], P = 0.016), solid metastatic cancers (OR: 5.63 [1.38-23.0], P = 0.016), and bloodstream infections (OR: 3.49 [1.02-12.0], P = 0.046) were independent risk factors for 28-day mortality. CONCLUSION: The significant risk factors for 28-day mortality in patients with CRE infections in Japan are mechanical ventilation, solid metastatic cancers, and bloodstream infections.


Carbapenem-Resistant Enterobacteriaceae , Enterobacteriaceae Infections , Sepsis , Humans , Carbapenem-Resistant Enterobacteriaceae/genetics , Carbapenems/pharmacology , Carbapenems/therapeutic use , Enterobacteriaceae Infections/drug therapy , Enterobacteriaceae Infections/epidemiology , Japan/epidemiology , Retrospective Studies , Treatment Outcome
5.
J Infect Chemother ; 27(8): 1193-1197, 2021 Aug.
Article En | MEDLINE | ID: mdl-33832848

INTRODUCTION: The aim of this study was to determine the rates of trimethoprim/sulfamethoxazole (TMP/SMX)-associated pseudo-elevation and true nephrotoxicity by comparison of creatinine-estimated and cystatin C-estimated GFRs (glomerular filtration rates) before and after TMP/SMX administrations. METHODS: Patients in whom serum creatinine and cystatin C were simultaneously measured are the cohort of this study. A decreasing of creatinine-estimated GFR posterior to TMP/SMX by ≥ 20% and a decreasing of cystatine C-estimated GFR posterior to TMP/SMX by ≥ 20% were defined as true nephrotoxicity. A decreasing of creatinine-estimated GFR posterior to TMP/SMX by ≥ 20% and a decreasing of cystatine C-estimated GFR posterior to TMP/SMX by < 20% were defined as pseudo-elevation. RESULTS: A total of 66 patients were enrolled. Within the 19 patients in whom serum creatinine and cystatin C were measured simultaneously both before and after TMP/SMX administrations, 10 patients (52.6%) had nephrotoxicity. Fewer random error and systematic bias between creatinine- and cystatine C-estimated GFR were observed after TMP/SMX than before TMP/SMX by Bland-Altman analysis. CONCLUSIONS: Using cystatin C, we reveled TMP/SMX-associated nephrotoxicity is not uncommon. We should equally pay attention to TMP/SMX-associated nephrotoxicity and pseudo-elevation. In spite of pseudo-elevation, creatinine-estimated GFR after receiving TMP/SMX is ironically reliable as surrogate maker for renal clearance.


Drug-Related Side Effects and Adverse Reactions , Renal Insufficiency , Creatinine , Glomerular Filtration Rate , Humans , Trimethoprim, Sulfamethoxazole Drug Combination/adverse effects
6.
Science ; 370(6521): 1230-1234, 2020 12 04.
Article En | MEDLINE | ID: mdl-33273103

Microorganisms in marine subsurface sediments substantially contribute to global biomass. Sediments warmer than 40°C account for roughly half the marine sediment volume, but the processes mediated by microbial populations in these hard-to-access environments are poorly understood. We investigated microbial life in up to 1.2-kilometer-deep and up to 120°C hot sediments in the Nankai Trough subduction zone. Above 45°C, concentrations of vegetative cells drop two orders of magnitude and endospores become more than 6000 times more abundant than vegetative cells. Methane is biologically produced and oxidized until sediments reach 80° to 85°C. In 100° to 120°C sediments, isotopic evidence and increased cell concentrations demonstrate the activity of acetate-degrading hyperthermophiles. Above 45°C, populated zones alternate with zones up to 192 meters thick where microbes were undetectable.


Endospore-Forming Bacteria/growth & development , Geologic Sediments/microbiology , Hot Temperature , Acetates/metabolism , Endospore-Forming Bacteria/metabolism , Geologic Sediments/chemistry , Methane/metabolism
7.
Sci Rep ; 10(1): 15952, 2020 09 29.
Article En | MEDLINE | ID: mdl-32994455

To determine the prophylactic effect of using combined 1% alcoholic chlorhexidine gluconate and chlorhexidine gel-impregnated dressings (CGCD) on catheter-related thrombosis (CRT) in critically ill patients. This retrospective cohort study was performed in an intensive care unit from November 2009 to August 2014. The CRT incidence diagnosed with ultrasound examination was compared between patients applying CGCD and combined 10% aqueous povidone-iodine and standard transparent dressings (PITD) after central venous catheter insertion into the internal jugular vein for ≥ 48 h. CRT was stratified into early (within 7 days) and late (days 8-14) thromboses. Multivariate analyses using logistic regression models clarified the relationships between early- and late-CRT risks and skin antiseptic and catheter site dressing combinations. CRT occurred in 74 of 134 patients (55%), including 52 with early CRT and 22 with late CRT. Patients receiving CGCD had a significantly lower incidence of early CRT than those receiving PITD (odds ratio = 0.18; 95% confidence interval = 0.07-0.45, p < .001). No significant association was evident between using CGCD and late CRT (p = .514). Compared to PITD, CGCD reduced the CRT risk over 7 days in critically ill patients.UMIN Clinical Trials Registry: UMIN000037492.


Catheterization, Central Venous/adverse effects , Catheterization, Central Venous/methods , Venous Thrombosis/surgery , Adult , Aged , Aged, 80 and over , Anti-Infective Agents, Local , Bandages , Catheter-Related Infections/etiology , Central Venous Catheters/adverse effects , Chlorhexidine/analogs & derivatives , Chlorhexidine/therapeutic use , Cohort Studies , Critical Illness , Equipment Contamination/prevention & control , Female , Gels/therapeutic use , Humans , Intensive Care Units , Japan/epidemiology , Male , Middle Aged , Odds Ratio , Povidone-Iodine/therapeutic use , Prophylactic Surgical Procedures/methods , Retrospective Studies , Risk Factors
8.
Int J Gen Med ; 13: 1669-1673, 2020.
Article En | MEDLINE | ID: mdl-33408504

A worldwide shortage of personal protective equipment during the COVID-19 pandemic has led to the development of new alternatives. We introduce two new disposable box-like head-and-face shields constructed using Japanese origami-style folding. The design comprises a single sheet of thick paper and a shield made of a thin, transparent plastic sheet. The first design, Model 1, is a head-and-face shield designed to cover the wearer's head and neck. Model 2 was designed to solve the problem of heat and moisture buildup inside the shield. This version can be used as face shields for patients, and it allows clinicians to collect swabs from the nasopharynx for virus detection via polymerase chain reaction through pre-cut incisions near the nasal orifices. These two new box-like face shields are excellent alternatives to traditional face shields because of the low cost, compatibility with mass production, lightweight, and disposability.

9.
J Infect Chemother ; 25(6): 437-443, 2019 Jun.
Article En | MEDLINE | ID: mdl-30782427

The objective of this study was to explore the optimal dosage regimen of daptomycin and to determine the necessity and validity of a high-dose regimen from the perspectives of PK/PD parameters using Monte Carlo Simulation (MCS) and therapeutic drug monitoring (TDM) in a Japanese clinical setting. The volume of distribution (0.13 ± 0.012 L/kg) in this study was greater than that in healthy volunteers reported in Japan. The range of half-lives was between 8.9 and 34.9 h, which were gradually prolonged as creatinine clearance decreased. In MCS, the cumulative fractions of response (CFR) of the peak/MIC â‰§ 60 and the AUC/MIC â‰§ 666 at the 6 mg/kg q 24 h were 72.0% and 78.8% but at the 10 mg/kg q 24 h, the CFRs improved to both 99%. In TDM with 6 mg/kg q 24 h regimen, the patients who reached the peak and AUC target were 40% (2 out of 5 patients), respectively. The intraindividual variability in daptomycin PK may indicate the necessity of TDM and high-dose regimen, such as over 8 mg/kg, may be needed to ensure the effectiveness especially on Japanese patients with normal renal function.


Anti-Bacterial Agents/pharmacology , Daptomycin/pharmacology , Methicillin-Resistant Staphylococcus aureus/drug effects , Staphylococcal Infections/drug therapy , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Area Under Curve , Creatinine/blood , Creatinine/metabolism , Creatinine/urine , Daptomycin/therapeutic use , Dose-Response Relationship, Drug , Drug Administration Schedule , Drug Monitoring/statistics & numerical data , Female , Half-Life , Humans , Infusions, Intravenous , Japan , Kidney/drug effects , Kidney/physiology , Male , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Microbial Sensitivity Tests , Middle Aged , Monte Carlo Method , Renal Elimination/drug effects , Staphylococcal Infections/blood , Staphylococcal Infections/microbiology , Staphylococcal Infections/urine , Treatment Outcome
10.
J Infect Chemother ; 24(11): 881-886, 2018 Nov.
Article En | MEDLINE | ID: mdl-30139692

OBJECTIVE: To study how and to what degree the rapid pathogen identification by MALDI-TOF MS coupled with rapid disk diffusion test improve the current clinical practice of patients with bacteremia in a tertiary teaching hospital with full-time ID consultation service. PATIENTS AND METHODS: MALDI-TOF MS and 8H disk diffusion tests were directly applied to the positive blood cultures samples and the results were reflected on antimicrobial therapy (n = 119). The appropriateness of antimicrobial selection through these interventions was verified with conventional culture results in comparison with historical control (n = 129). The mortality of patients between the two periods was also compared. RESULTS: The appropriateness of antimicrobial selection was higher (99.2%) in the intervention than in the control group (93.8%) (p 0.024), but there was no difference in 28-day mortality between the two periods (16.8%, 14.8%) (p 0.668). The duration of presumptive antimicrobial therapy with anti-MRSA agents and carbapenem antibiotics did not differ between the two periods indicating that the intervention was not effective in decreasing the unnecessary antibiotics. On the other hand, some bacteremic patients with pathogens whose drug susceptibilities were invariably sensitive to the standard class of antibiotics definitely benefitted from the intervention. CONCLUSION: The intervention utilizing MALDI-TOF MS and the rapid disk diffusion test may not demonstrate overall improvement in bacteremia mortality in the institution with full-time infectious disease consultants. Its utility has yet to be evaluated in different setting hospitals.


Anti-Bacterial Agents/pharmacology , Bacteremia/drug therapy , Bacteria/isolation & purification , Disk Diffusion Antimicrobial Tests/methods , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods , Aged , Anti-Bacterial Agents/therapeutic use , Bacteremia/microbiology , Bacteremia/mortality , Bacteria/drug effects , Bacterial Physiological Phenomena , Female , Humans , Male , Middle Aged , Time Factors , Treatment Outcome
11.
Sci Rep ; 8(1): 2622, 2018 02 14.
Article En | MEDLINE | ID: mdl-29445141

A new method for evaluating the in situ rock strength beneath the seafloor is proposed and applied to the Nankai Trough accretionary prism. The depth-continuous in situ rock strength is a critical parameter for numerous studies in earth science, particularly for seismology and tectonics at plate convergence zones; yet, measurements are limited owing to a lack of drilled cores. Here, we propose a new indicator of strength, the equivalent strength (EST), which is determined only by drilling performance parameters such as drill string rotational torque, bit depth, and string rotational speed. A continuous depth profile of EST was drawn from 0 to 3000 m below the seafloor (mbsf) across the forearc basin and accretionary prism in the Nankai Trough. The EST did not show a significant increase around the forearc basin-accretionary prism boundary, but it did show a clear increase within the prism, ca. below 1500 mbsf. This result may indicate that even the shallow accretionary prism has been strengthened by horizontal compression derived from plate subduction. The EST is a potential parameter to continuously evaluate the in situ rock strength during drilling, and its accuracy of the absolute value can be improved by combining with laboratory drilling experiments.

12.
J Biosci Bioeng ; 124(3): 359-364, 2017 Sep.
Article En | MEDLINE | ID: mdl-28457659

To simultaneously sequence and quantify target DNA, quantitative sequencing (qSeq) employs stochastic labeling of target DNA molecules with random-sequence tags (RSTs). This recently developed approach allows parallel quantification of hundreds of microorganisms in natural habitats in a single sequencing run. Yet, no study has addressed to what extent sequencing errors affect quantification and how many sequence reads are needed for quantification. Here, we addressed those issues by using numerical simulations and experimental data from second-generation sequencing of various RSTs. We found that heterogeneous distribution of observed RSTs affected the number of sequence reads required to quantitate target genes, whereas the effect of sequencing errors is smaller than of the RSTs distribution. Because of the heterogeneous RSTs distribution, 15-fold more sequence reads than the number of observed RSTs should be obtained to retrieve almost all RSTs needed for quantification; in that case, quantification error is estimated to be within 5%.


Sequence Analysis, DNA/methods , DNA/genetics , Halobacteriaceae/genetics , RNA, Ribosomal, 16S/genetics , Research Design , Sequence Analysis, DNA/standards , Stochastic Processes
13.
Intern Med ; 56(5): 487-491, 2017.
Article En | MEDLINE | ID: mdl-28250292

Objective Legionnaires' disease (LD) is a common form of lobar pneumonia, but the optimum diagnostic modality has long been a subject of debate due to incomplete sensitivity and specificity. A delay in the initiation of specific therapy for LD is associated with increased mortality. The decision to treat a patient for Legionella must be made quickly. The purpose of this study was to evaluate the ability of the modified Winthrop-University Hospital WUH system to identify LD while discriminating against pneumococcal pneumonia at the time of hospitalization for community-acquired pneumonia. Methods Five patients with LD and 13 patients with pneumococcal pneumonia were retrospectively analyzed. Results The WUH system identified 4 of 5 patients with LD (sensitivity, 80%) while excluding legionellosis in 12 of 13 patients with pneumococcal pneumonia (specificity, 92%). The positive and negative likelihood ratios were 10.4 and 0.2. The area under the receiver operating characteristic curve was 0.969. Conclusion The WUH system is useful for obtaining a rapid presumptive clinical diagnosis of LD. Further investigation with a larger number of patients is strongly recommended.


Legionnaires' Disease/diagnosis , Pneumonia, Pneumococcal/diagnosis , Adult , Aged , Community-Acquired Infections/diagnosis , Diagnosis, Differential , Female , Hospitalization , Hospitals, University , Humans , Legionnaires' Disease/complications , Male , Middle Aged , Pneumonia, Pneumococcal/complications , Retrospective Studies , Sensitivity and Specificity
14.
J Infect Chemother ; 21(9): 695-9, 2015 Sep.
Article En | MEDLINE | ID: mdl-26184852

A 61-year-old man was admitted to our hospital with 2-day history of malaise and dyspnea. He had mitral prolapse and type II diabetes mellitus with neurogenic bladder, which was cared for by catheterization on his own. On arrival the patient was in septic condition with hypoxemia, and physical examination revealed systolic murmur at the apex. Transthoracic echocardiography revealed vegetation of the mitral and the aortic valve. The presence of continuous bacteremia was confirmed by multiple sets of blood culture, whereby gram-positive cocci was retrieved and identified as Staphylococcus saprophyticus (S. saprophyticus) both phenotypically and genetically. Because two major criteria of the Modified Duke Criteria were met, the patient was diagnosed with native valve endocarditis due to S. saprophyticus. The urine culture was also positive for gram-positive cocci, phenotypically identified as Staphylococcus warneri, which was subsequently identified as S. saprophyticus with the use of 16S rRNA gene sequence analysis and MALDI-TOF MS (matrix-assisted laser desorption ionization time of flight mass spectrometry), indicating strongly that the intermittent catheterization-associated urinary tract infection resulted in bacteremia that eventually lead to infective endocarditis. This patient was treated with vancomycin and clindamycin. Because of multiple cerebral infarctions, the patient underwent mitral and aortic valve replacement on hospital day 5. Blood culture turned negative at 6th hospital day. Antibiotic therapy was continued for six weeks after surgery. The patient's clinical course was uneventful thereafter, and was discharged home. This is the first case report of native valve endocarditis caused by S. saprophyticus of confirmed urinary origin.


Aortic Valve , Endocarditis, Bacterial/microbiology , Heart Valve Diseases/microbiology , Mitral Valve , Staphylococcal Infections/complications , Staphylococcus saprophyticus/isolation & purification , Urinary Tract Infections/complications , Bacteremia/microbiology , Diabetes Mellitus, Type 2/complications , Humans , Intermittent Urethral Catheterization/adverse effects , Male , Middle Aged , Urinary Bladder, Neurogenic/complications , Urinary Bladder, Neurogenic/therapy
15.
Int J Infect Dis ; 37: 70-6, 2015 Aug.
Article En | MEDLINE | ID: mdl-26113110

OBJECTIVE: To investigate the association between anorectal precancerous lesions, including condyloma, and sexually transmitted infections (STI) in Asian population. METHODS: This prospective study enrolled 2677 patients who underwent high-resolution colonoscopy for anorectal cancer screening. Anorectal lesions were diagnosed based on endoscopic findings and confirmed by biopsy. The association of HIV-1 infection, syphilis, and HBV infection with anorectal lesion was estimated by multivariate logistic regression. In HIV-1-infected patients (n=244), anal canal HPV-DNA was screened and genotyped. RESULTS: Although no malignancy was identified, anorectal condyloma was diagnosed in 32 (1.2%) male patients. 41% of anorectal condyloma cases had no specific lower GI symptoms. Multivariate analysis identified HIV-1 infection, but not syphilis or HBV infection, as an independent significant factor for condyloma (OR: 176.5, 95%CI 22.52-1383, p<0.001). In HIV-1 infected patients, positive type 16/18 HPV-DNA (OR: 4.766, 95%CI 1.838-12.36, p=0.001), lower CD4 cell count (per 100/µl decrement, OR: 1.056, 95%CI 1.056-1.587, p=0.013), and current smoking (OR: 3.828, 95%CI 1.486-9.857, p=0.005) were independently associated with anorectal condyloma. CONCLUSIONS: HIV-1 infection, but not syphilis or HBV infection, was identified as a strong risk for anorectal condyloma. Anal HPV 16/18 was highly prevalent in patients with HIV-1 infection, especially in those with condyloma.


Anus Diseases/epidemiology , Condylomata Acuminata/epidemiology , HIV Infections/complications , HIV-1 , Rectal Diseases/epidemiology , Adult , Aged , Anus Diseases/pathology , Anus Diseases/virology , Asian People , Colonoscopy , Condylomata Acuminata/pathology , Condylomata Acuminata/virology , Cross-Sectional Studies , Female , Hepatitis B/complications , Humans , Male , Mass Screening , Middle Aged , Prevalence , Prospective Studies , Rectal Diseases/pathology , Rectal Diseases/virology , Risk Factors , Sexually Transmitted Diseases/complications , Syphilis/complications
16.
J Infect Chemother ; 21(7): 527-30, 2015 Jul.
Article En | MEDLINE | ID: mdl-25935477

Enterococcus consists human bowel flora, but sometimes behave as an important nosocomial pathogen. In order to identify clinical characteristics that help discriminate between ampicillin-susceptible and ampicillin-resistant enterococcal bacteremia in advance for antimicrobial susceptibility testing, a retrospective eight-year study was carried out in patients with enterococcal bacteremia experienced in Saga University Hospital, Japan. A total of 143 patients were included in the analysis: 85 (59.4%) with bacteremia caused by ampicillin-susceptible enterococci and 58 (40.6%) by ampicillin-resistant strains. Hospital-acquired bacteremia was present in 79.0% (113/143) of patients. Abdominal infections, urinary tract infections, and unknown source were predominant foci for the two groups. Patients with ampicillin-resistant enterococcal bacteremia was significantly associated with hematological cancer, immunosuppressive therapy, prior use of antibiotics, and mucositis associated with febrile neutropenia. The 28-day mortality was significantly higher in ampicillin-resistant enterococcal bacteremia. On multivariate analysis, independent risk factors for ampicillin-resistant enterococci were as follows: prior exposures to penicillins and carbapenems, and bacteremia related to mucositis with febrile neutropenia. These findings would assist physicians in deciding whether glycopeptide antibiotics should be included as an empiric antibiotic therapy in patients with suspected enterococcal infections and also those with persistent neutropenic fever refractory to fourth generation cephalosporin. A few cases of MALDI-TOF MS-identified Enterococcus faecium that turned out ampicillin-sensitive were also described to emphasize the importance of taking epidemiological aspects of patients into considerations when deciding initial antimicrobial treatment.


Ampicillin/pharmacology , Anti-Bacterial Agents/pharmacology , Bacteremia/epidemiology , Drug Resistance, Bacterial , Enterococcus/drug effects , Gram-Positive Bacterial Infections/epidemiology , Aged , Aged, 80 and over , Bacteremia/microbiology , Female , Gram-Positive Bacterial Infections/microbiology , Humans , Male , Middle Aged , Retrospective Studies , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Vancomycin/pharmacology
17.
J Infect Chemother ; 20(12): 810-3, 2014 Dec.
Article En | MEDLINE | ID: mdl-25153621

A 74-year-old man presented with sudden onset of aphasia and apraxia. Magnetic resonance image (MRI) of the brain disclosed a left frontal hemorrhage. The concomitant low grade fever suggestive of infection was unresponsive to cefazolin 1 g q12h, and refractory to piperacillin (PIPC) 2 g q8h. Blood culture grew enterococci, establishing together with echocardiography the diagnosis of infective endocarditis. The angiography revealed cerebral hemorrhage to have resulted from the rupture of the infected intracranial aneurysm. The antimicrobial therapy was switched to ampicillin (ABPC) 2 g q4h plus gentamicin (GM) 60 mg q8h. The positive blood culture was subsequently identified Enterococcus faecium to which the minimum inhibitory concentration (MIC) of PIPC, and ABPC was 16 mcg/mL, and 4 mcg/mL, respectively. The peak concentration of serum ABPC was 83.1, median 50.8, and trough 25.8 mcg/mL. Thus, the percent time > MIC for ABPC was 100%, and the time > minimum bactericidal concentration (MBC) as well. On the other hand, time > MIC for PIPC, was found nearly 30% in retrospective analysis using population pharmacokinetics. The neurological deficit of the patient was completely restored to the normal status after 4-weeks' antimicrobial therapy with ABPC plus GM, then he underwent cardiac surgery for valvular replacement, where microbiological culture of the resected valve was negative. The constellation of the clinical, pharmacological and microbiological outcome in our case provides scientific evidence that the antibiotic therapy given to our case is the best available strategy as an antimicrobial treatment of severe enterococcal endocarditis complicated by disseminated lesion as infected intracranial aneurysm.


Aneurysm, Ruptured/microbiology , Anti-Bacterial Agents/pharmacology , Endocarditis, Bacterial/drug therapy , Enterococcus faecium/drug effects , Gram-Positive Bacterial Infections/drug therapy , Intracranial Aneurysm/microbiology , Aged , Ampicillin/pharmacokinetics , Ampicillin/pharmacology , Ampicillin/therapeutic use , Anti-Bacterial Agents/pharmacokinetics , Anti-Bacterial Agents/therapeutic use , Brain/pathology , Endocarditis, Bacterial/metabolism , Endocarditis, Bacterial/microbiology , Gram-Positive Bacterial Infections/metabolism , Gram-Positive Bacterial Infections/microbiology , Humans , Magnetic Resonance Imaging , Male , Microbial Sensitivity Tests , Treatment Outcome
18.
J Antimicrob Chemother ; 69(12): 3320-8, 2014 Dec.
Article En | MEDLINE | ID: mdl-25151207

OBJECTIVES: Ritonavir-boosted atazanavir (atazanavir/ritonavir) is a widely used antiretroviral drug, though it can potentially cause nephrolithiasis. The aim of this study was to determine the relationship between polymorphisms in genes encoding proteins involved in metabolism and transportation of atazanavir, and atazanavir/ritonavir-induced nephrolithiasis in HIV-1-infected patients treated with atazanavir/ritonavir. METHODS: Nineteen SNPs in the ABCB1, NR1I2, UGT1A1, SLCO1B1 and CYP3A5 genes were examined in case patients with atazanavir/ritonavir-induced nephrolithiasis (n = 31) and controls (n = 47). Case patients were those with a clinical diagnosis of nephrolithiasis while on atazanavir/ritonavir, based on new-onset acute flank pain plus one of the following: (i) new-onset haematuria; (ii) documented presence of stones by either abdominal ultrasonography or CT; or (iii) confirmed stone passage. Control patients were consecutively enrolled among those with >2 years of atazanavir/ritonavir exposure free of nephrolithiasis. Genotyping was performed by allelic discrimination using TaqMan 5'-nuclease assays with standard protocols. Associations between alleles and atazanavir/ritonavir-induced nephrolithiasis were tested by univariate and multivariate logistic regression analyses. RESULTS: Multivariate analysis showed a significant association between atazanavir/ritonavir-induced nephrolithiasis and genotype T/C versus C/C at position c.211 (adjusted OR = 3.7; 95% CI, 1.13-11.9; P = 0.030), genotype G/C versus C/C at 339 (adjusted OR = 5.8; 95% CI, 1.56-21.3; P = 0.009) and genotype G/G or G/C versus C/C at 440 (adjusted OR = 5.8; 95% CI, 1.56-21.3; P = 0.009) of the UGT1A-3' untranslated region (UTR). CONCLUSIONS: This is the first known study to identify the association between SNPs in the UGT1A-3'-UTR and atazanavir-induced nephrolithiasis. Further studies are warranted to confirm this association and to elucidate how these SNPs might influence atazanavir exposure.


3' Untranslated Regions , Glucuronosyltransferase/genetics , HIV Infections/complications , HIV Infections/drug therapy , Nephrolithiasis/chemically induced , Oligopeptides/adverse effects , Polymorphism, Single Nucleotide , Pyridines/adverse effects , Adolescent , Adult , Aged , Atazanavir Sulfate , Case-Control Studies , Female , Genotype , Genotyping Techniques , HIV Infections/virology , HIV-1/isolation & purification , Humans , Male , Middle Aged , Oligopeptides/therapeutic use , Pyridines/therapeutic use , Young Adult
19.
J Acquir Immune Defic Syndr ; 65(3): 312-7, 2014 Mar 01.
Article En | MEDLINE | ID: mdl-24525468

BACKGROUND: Non-AIDS defining cancer has recently become a major problem in HIV-infected patients. Little has been reported on whether HIV infection is a risk factor for colorectal adenoma, especially in Asians. METHODS: The study was conducted under a prospective cross-sectional design and included all adults who underwent colonoscopy. Subjects were matched by age and sex to compare the prevalence of colorectal adenoma, adenocarcinoma, polyps, and other tumors. Detailed risk factors were assessed, including lifestyle habits, medications, comorbidities, gastrointestinal symptom rating scale, HIV-associated factors, and human papillomavirus infection. To evaluate the effects of HIV infection on adenoma, the odds ratio (OR) was estimated by multivariate logistic regression. RESULTS: A total of 177 HIV-infected patients and 177 controls were selected for analysis. No significant difference was noted in the prevalence of adenoma (n = 29 vs. 40, P = 0.14). Multivariate analysis adjusted by baseline demographics and risk factors showed that HIV is not associated with increased risk of adenoma (adjusted OR = 0.66, P = 0.16). Kaposi's sarcoma was more common in HIV-infected patients (n = 6 vs. 0, P = 0.03). Among HIV-infected patients, advanced age was an independent and significant risk factor for adenoma (adjusted OR = 2.28, P < 0.01). CD4 count, HIV-RNA, history of antiretroviral treatment, and oncogenic human papillomavirus infection were not risk factors for adenoma. CONCLUSIONS: HIV infection was not identified as risk for adenoma in Asian patients. However, advanced age was independently associated with increased risk of adenoma. HIV-infected patients should not miss screening opportunity for colorectal adenoma and other gastrointestinal malignancies.


Adenoma/diagnosis , Adenoma/epidemiology , Colonoscopy , Colorectal Neoplasms/diagnosis , Colorectal Neoplasms/epidemiology , HIV Infections/complications , Adenoma/pathology , Adult , Age Factors , Asia/epidemiology , Colorectal Neoplasms/pathology , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Papillomavirus Infections/diagnosis , Prospective Studies , Risk Factors
20.
J Antimicrob Chemother ; 69(5): 1385-9, 2014 May.
Article En | MEDLINE | ID: mdl-24379301

OBJECTIVES: This study aimed to examine the effect of long-term treatment with ritonavir-boosted atazanavir (atazanavir/ritonavir) on cholelithiasis. METHODS: A single-centre, cross-sectional study was conducted to elucidate the prevalence of cholelithiasis in patients with HIV-1 infection who underwent abdominal ultrasonography between January 2004 and March 2013. Univariate and multivariate logistic regression analyses were applied to estimate the effects of >2 years of atazanavir/ritonavir exposure on cholelithiasis as the primary exposure. RESULTS: Of the 890 study patients, 84 (9.4%) had >2 years of atazanavir/ritonavir exposure. Cholelithiasis was twice as frequent in those treated for >2 years with atazanavir/ritonavir [15 (18%) of 84 patients] compared with those treated for <2 years [72 (8.9%) of 806 patients] (P = 0.018). Univariate analysis showed a significant association between >2 years of atazanavir/ritonavir exposure and cholelithiasis (OR = 2.216; 95% CI = 1.206-4.073; P = 0.010) and the association almost persisted in multivariate analysis (adjusted OR = 1.806; 95% CI = 0.922-3.537; P = 0.085). Long-term treatment (>2 years) with other commonly used protease inhibitors, such as ritonavir-boosted lopinavir and ritonavir-boosted darunavir, was not associated with cholelithiasis in univariate and multivariate analysis. Additional analysis showed that >1 year of exposure to atazanavir/ritonavir was significantly associated with cholelithiasis (OR = 1.857; 95% CI = 1.073-3.214; P = 0.027), whereas >1 year of exposure to ritonavir-boosted lopinavir and ritonavir-boosted darunavir was not. CONCLUSIONS: Long-term treatment of patients with HIV-1 infection for >2 years with atazanavir/ritonavir was associated with an increased risk of cholelithiasis compared with patients with shorter exposure. Long-term exposure to atazanavir/ritonavir appears to increase the risk of cholelithiasis in patients with HIV-1 infection.


Anti-HIV Agents/therapeutic use , Cholelithiasis/chemically induced , Cholelithiasis/epidemiology , HIV Infections/complications , HIV Infections/drug therapy , Oligopeptides/therapeutic use , Pyridines/therapeutic use , Ritonavir/therapeutic use , Abdomen/diagnostic imaging , Adult , Anti-HIV Agents/adverse effects , Atazanavir Sulfate , Cross-Sectional Studies , Female , HIV Infections/virology , HIV-1/isolation & purification , Humans , Male , Oligopeptides/adverse effects , Prevalence , Pyridines/adverse effects , Ritonavir/adverse effects , Time Factors , Ultrasonography
...